Rawcliffe Adrian (CIK 1555851) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-12-10). Recent activity: Buy WVE (42,000 shares), Sell WVE (42,000 shares), Sell WVE (16,115 shares), Buy WVE (12,700 shares), Sell ADAP (30,601 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 42,000 | $250,740 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 42,000 | $630,000 |
| 2025-11-14 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 16,115 | $109,421 |
| 2025-08-13 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 12,700 | $0 |
| 2025-01-17 | Adaptimmune Therapeutics PLC (ADAP) | Chief Executive Officer | Sell | 30,601 | $17,749 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Executive Officer | Sell | 12,539 | $7,398 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Executive Officer | Sell | 17,934 | $10,581 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Executive Officer | Sell | 29,096 | $16,585 |
Source: SEC Form 4 filings · as of 2025-12-10